ImmuMap is proud to have participated in T-cell Elispot Proficiency Panel 2019 with excellent results
The Elispot Proficiency Panel allows laboratories worldwide to test their proficiency in enumeration of antigen specific T cells using the T-cell Elispot assay. The Proficiency Panel is coordinated and conducted by Immudex in collaboration with CIC (the US Cancer Immunotherapy Consortium of the Cancer Research Institute) and CIMT (the European Association for Cancer Immunotherapy).
Making accurate, reproducible and state-of-the-art T cell immune monitoring analysis is becoming increasingly important in immunotherapeutic research and development. Proficiency panels is used to evaluate assay performance in any laboratory with a desire to perform reliable immune monitoring and accurate enumeration of antigen-specific T cells. 43 laboratories from 13 countries have participated in the Elispot proficiency panel 2019 and only 65% of the participants’ obtained aligned results.
ImmuMap has chosen to participate in the T-cell Elispot Proficiency Panel 2019 in order to validate our lab’s performance of T-cell Elipsot assays. We have confirmed that our lab is capable of accurate, reproducible and state-of-the-art T cell immune analysis.
Check out the report at: